![Josh Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josh Cohen
Founder at
AMYLYX PHARMACEUTICALS, INC.
Net worth: 105 M $ as of 30/09/2026
Profile
Mr. Joshua B. Cohen is an Independent Director at TCGX Acquisition Corp.
II and a Co-Chief Executive Officer & Director at Amylyx Pharmaceuticals, Inc. He is on the Board of Directors at TCGX Acquisition Corp.
II, Amylyx Pharmaceuticals, Inc. and Practice XYZ LLC.
Mr. Cohen was previously employed as a Founder by Brown Biotechnology Investment Group.
He received his undergraduate degree from Brown University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/09/2026 | 3,613,123 ( 3.27% ) | 105 M $ | 30/09/2026 | |
1.2% | 19/10/2026 | 30,000 ( 1.2% ) | 325 800 $ | 30/09/2026 |
Josh Cohen active positions
| Companies | Position | Start |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Founder | 01/01/2013 |
Practice XYZ LLC
 Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Director/Board Member | - |
Former positions of Josh Cohen
| Companies | Position | End |
|---|---|---|
Brown Biotechnology Investment Group | Founder | - |
Education of Josh Cohen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Technology Services |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
 Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Brown Biotechnology Investment Group |
- Stock Market
- Insiders
- Josh Cohen
